Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Privia Health Group Inc
NASDAQ:PRVA

Watchlist Manager
Privia Health Group Inc Logo
Privia Health Group Inc
NASDAQ:PRVA
Watchlist
Price: 19.39 USD 1.52% Market Closed
Market Cap: $2.4B
Write Note Create Alert Ask AI

Wall St Price Targets

PRVA Price Forecast
Based on 20 analysts

+63% Upside
from $19.39 today

PRVA Analyst Rating
Based on 21 analysts

Strong buy
14 67%
Buy
5 24%
Hold
2 10%
Sell
0 0%
Strong sell
0 0%
Privia Health Group Inc Competitors:
Price Targets

Revenue
Forecast

18% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-41%
Average Miss
18% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-41%
Average Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 6 years is 9%.

What are analyst estimates?

Gross Profit
Forecast

20% / Year
Past Growth
47% / Year
Estimated Growth
Estimates Accuracy
-41%
Average Miss
20% / Year
Past Growth
47% / Year
Estimated Growth
Estimates Accuracy
-41%
Average Miss

Over the last 6 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 2 years is 47%.

What are analyst estimates?

Operating Income
Forecast

13% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
13% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 6 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 6 years is 33%.

What are analyst estimates?

Pre-Tax Income
Forecast

30% / Year
Past Growth
50% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss
30% / Year
Past Growth
50% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 30%. The projected CAGR for the next 3 years is 50%.

What are analyst estimates?

Net Income
Forecast

19% / Year
Past Growth
54% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
19% / Year
Past Growth
54% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Over the last 6 years, the compound annual growth rate for Net Income has been 19%. The projected CAGR for the next 3 years is 54%.

What are analyst estimates?

Continue PRVA Research

Summary
PRVA intrinsic value, competitors valuation, and company profile.
DCF Valuation
PRVA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PRVA stock valuation using valuation multiples.
Wall St Estimates
PRVA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PRVA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PRVA's stock price target?
Price Target
31.62 USD

According to Wall Street analysts, the average 1-year price target for PRVA is 31.62 USD with a low forecast of 24.24 USD and a high forecast of 42 USD.

What is the Revenue forecast for Privia Health Group Inc?
Projected CAGR
9%

Over the last 6 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 6 years is 9%.

What is the Gross Profit forecast for Privia Health Group Inc?
Projected CAGR
47%

Over the last 6 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 2 years is 47%.

What is the Operating Income forecast for Privia Health Group Inc?
Projected CAGR
33%

Over the last 6 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 6 years is 33%.

What is the Pre-Tax Income forecast for Privia Health Group Inc?
Projected CAGR
50%

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 30%. The projected CAGR for the next 3 years is 50%.

What is the Net Income forecast for Privia Health Group Inc?
Projected CAGR
54%

Over the last 6 years, the compound annual growth rate for Net Income has been 19%. The projected CAGR for the next 3 years is 54%.

Back to Top
ALPHA SPREAD
Follow us
Join 359,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.